Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer

Background: Radiotherapy is one of the primary therapies for localized prostatic carcinoma. Therefore, there is an emerging need to sensitize prostatic cancer cells to chemotherapy/radiotherapy. Modified citrus pectin (MCP) is an effective inhibitor of galectin-3 (Gal-3), which is correlated with tu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Integr Cancer Ther
Main Authors: Conti, Sefora, Vexler, Akiva, Hagoel, Lior, Kalich-Philosoph, Lital, Corn, Benjamin W., Honig, Nir, Shtraus, Natan, Meir, Yaron, Ron, Ilan, Eliaz, Isaac, Lev-Ari, Shahar
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2018
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247563/
https://ncbi.nlm.nih.gov/pubmed/30043669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418790382
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki